Kreatech Biotechnology, GE Healthcare, Pharma, Beckman Coulter, US Senate | GenomeWeb

Kreatech to Use GE Healthcare
Dyes in Microarray Labeling Kits

Kreatech Biotechnology said this week that it has signed an agreement allowing it to use GE Healthcare's fluorescent dye technology in DNA microarray-labeling kits.

Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.